AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 53 min read$NATR

Nature's Sunshine (NATR) Q2 Earnings Report Preview: What To Look For

Nature’s Sunshine (NATR) will report Q2 earnings Thursday after the bell. The company previously reported Q1 revenue of $122.9M, up 8.5% YoY, and beat analysts on EPS and EBITDA. For Q2, analysts expect revenue up 7.8% YoY. The article cites an average analyst price target of $34.50 vs a $20.45 share price.

Original reporting
financialcontent.com
Published Aug 5, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 4:45 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Nature's Sunshine (NATR) Q2 Earnings Report Preview: What To Look For — source image
Source · financialcontent.com
Decision brief

The 30-second read

$NATRNeutralMed
01

Why it matters

The main tradable element is the earnings timing plus consensus revenue growth and the stock’s relative underperformance versus the personal care segment, which can influence expectations and positioning into the print.

02

Market read

This preview frames what to watch in NATR’s upcoming earnings, using consensus growth, prior-quarter performance, and peer read-across.

03

What to watch

No guidance, margin drivers, or product/order details are provided, so traders may be underestimating the risk that the market focuses on profitability or forward commentary rather than revenue growth.

Relevance 4/10Novelty 4/10Timing: pre-market into Thursday after-the-bell earnings

Background

Nature’s Sunshine is previewed ahead of its Q2 earnings release after the bell on Thursday, following a prior-quarter revenue and EPS/EBITDA beat.

Company-level read

Ticker impact

$NATRNeutralMedium confidence
Context

Nature’s Sunshine is set to report Q2 earnings after the bell, with the article citing revenue growth expectations and recent estimate reconfirmations.

Expected impact

Near-term volatility is likely around the after-hours earnings print, with upside/downside driven by whether revenue growth and margins/EBITDA align with expectations.

Evidence & confidence

The article provides consensus growth (7.8% YoY) and notes prior-quarter beats, but it does not disclose any new company-specific development beyond the upcoming earnings timing and estimate context.

Market effects

Sector

Personal care peers’ mixed Q2 results (Medifast down YoY, USANA down YoY) may shape read-across expectations for NATR’s margin and demand signals.

Regional

None stated.

Global

None stated.

Counterpoint

What could challenge this read

Because the article stresses that NATR “rarely misses” revenue estimates, the market may instead trade the earnings quality (EBITDA/margins) rather than the top-line beat.

Key entities

  • company
    Nature’s Sunshine

    NASDAQ-listed wellness products company scheduled to report Q2 earnings after the bell Thursday.

  • company
    Medifast

    Personal care peer referenced for its Q2 revenue decline and post-results stock reaction.

  • company
    USANA

    Personal care peer referenced for its Q2 revenue decline and miss versus expectations.

Read at source← All news

Related articles

AUG 17
$NATRMed

Nature’s Sunshine (NATR) Lays Out a $1B Growth Target Amid Guidance Cuts

Nature’s Sunshine Products (NATR) reported Q2 net sales of $117M and gross margin of 73.7%, its strongest second quarter. Management said North America digital sales rose 26% and subscription/autoship drove growth. It cut full-year net sales guidance to $490M-$500M and EBITDA to $48M-$52M, citing currency effects and a China sales reversal.

yahoo.com4 min
AUG 14
$NATRMedAI 8/10

Nature's Sunshine (NATR) Q2 2026 Earnings Call Transcript

Nature's Sunshine Products (NATR) reported Q2 2026 net sales of $117.0 million (+2%, or +4% excluding FX), gross margin of 73.7%, GAAP net income of $3.5 million ($0.19/share), and adjusted EBITDA of $11.3 million. Full-year 2026 sales guidance was cut to $490-$500 million and adjusted EBITDA to $48-$52 million. China sales fell 20% while Japan rose 50%.

fool.com6 min
AUG 7
$NATRMedAI 8/10

Nature's Sunshine (NATR) Stock Trades Down, Here Is Why

Nature’s Sunshine (NASDAQ: NATR) shares fell 17.7% after the company reported Q2 2026 results that missed Wall Street. Revenue was $117 million, 5.4% below estimates, and adjusted EPS was $0.21, 22.2% below expectations. It also cut full-year revenue guidance to $495 million at the midpoint, down 2.5% from prior guidance.

financialcontent.com4 min
AUG 6
$NATRMed

NATURES SUNSHINE PRODUCTS INC (NATR): Results of Operations and Financial Condition

NATURES SUNSHINE PRODUCTS INC (NATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Nature's Sunshine Reports Second Quarter 2026 Results Net Sales up 2% to $117.0 million, Gross Profit Margin up 194 Basis Points to 73.7% LEHI, Utah – August 6, 2026 – Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Nature’s Sunshine"), a global leader in manufacturing and mark

SEC EDGAR 8-K6 min